Global Prostate Cancer Therapeutics Market to Reach $23.6 Billion by 2030

ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, March 09, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Prostate Cancer Therapeutics Industry" - https://www.reportlinker.com/p03915682/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Prostate Cancer Therapeutics Market to Reach $23.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Prostate Cancer Therapeutics estimated at US$14.9 Billion in the year 2022, is projected to reach a revised size of US$23.6 Billion by 2030, growing at aCAGR of 6% over the period 2022-2030. Hormone Therapy, one of the segments analyzed in the report, is projected to record 6.2% CAGR and reach US$18.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Targeted Therapy segment is readjusted to a revised 5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.4 Billion, While China is Forecast to Grow at 5.3% CAGR

The Prostate Cancer Therapeutics market in the U.S. is estimated at US$4.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$4 Billion by the year 2030 trailing a CAGR of 5.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Select Competitors (Total 76 Featured)
- AbbVie Inc.
- Allergan plc
- Amgen Inc.
- Astellas Pharma Inc.
- AstraZeneca Plc.
- Bayer AG
- Bristol-Myers Squibb Company
- Debiopharm Group
- Endo Pharmaceuticals Inc.
- F. Hoffmann-La Roche Ltd.
- Genentech Inc.
- GlaxoSmithKline Plc
- Janssen Biotech Inc.
- Novartis AG
- Pfizer Inc.
- Progenics Pharmaceuticals Inc.
- Sanofi S.A.
- Spectrum Pharmaceuticals Inc.
- Takeda Pharmaceutical Company Limited
- TOLMAR Pharmaceuticals Inc.


Read the full report: https://www.reportlinker.com/p03915682/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Recent Market Activity
An Insight in the Global Market for Prostate Cancer Diagnostics
and Therapeutics
Rising Incidence of Prostate Cancer: Cornerstone for the Market
Current & Future Analysis
Developing Countries Turbo Charge Future Market Growth
An Insight into the Castration-Resistant Prostate Cancer
Therapeutics Market
Hormone Therapies to Dominate Global Prostate Cancer
Therapeutics Market
Key Prostate Cancer Hormone Therapy Drugs & Companies: 2017
Targeted Therapy - The New Frontier of Cancer Treatment
Radiotherapy - Gaining Prominence
Metastatic Prostate Cancer - Apt for Precision Oncology
Launch of Generic Drugs to Place Established Players in Jeopardy
Demographics & Lifestyles Raise the Risk of Prostate Cancer
Select General Risk Factors and their Relative Risk Rate in
Prostate Cancer
Small Cap Companies: A Target of Private Capital Financing
Cost Analysis of Currently Available Treatment
Growth Drivers
Growth Restraints
Pipeline of Drugs in Clinical Trials
Innovations & Advancements
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Prostate Cancer Therapeutics - Global Key Competitors
Percentage Market Share in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Prostate Cancer Therapeutics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 3: World 16-Year Perspective for Prostate Cancer
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Hormone Therapy by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 5: World Historic Review for Hormone Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 6: World 16-Year Perspective for Hormone Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Targeted Therapy by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 8: World Historic Review for Targeted Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 9: World 16-Year Perspective for Targeted Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Chemotherapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 11: World Historic Review for Chemotherapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Chemotherapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Hospital Pharmacies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 14: World Historic Review for Hospital Pharmacies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 15: World 16-Year Perspective for Hospital Pharmacies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Retail Pharmacies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 17: World Historic Review for Retail Pharmacies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 18: World 16-Year Perspective for Retail Pharmacies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Online Sales by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 20: World Historic Review for Online Sales by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 21: World 16-Year Perspective for Online Sales by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Other Distribution Channels by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 23: World Historic Review for Other Distribution Channels
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Other Distribution
Channels by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2014, 2023 & 2030

Table 25: World Prostate Cancer Therapeutics Market Analysis of
Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
Prostate Cancer Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United States for 2023
(E)
Table 26: USA Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy,
Targeted Therapy and Chemotherapy - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 27: USA Historic Review for Prostate Cancer Therapeutics
by Therapy Type - Hormone Therapy, Targeted Therapy and
Chemotherapy Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 28: USA 16-Year Perspective for Prostate Cancer
Therapeutics by Therapy Type - Percentage Breakdown of Value
Sales for Hormone Therapy, Targeted Therapy and Chemotherapy
for the Years 2014, 2023 & 2030

Table 29: USA Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Distribution Channel - Hospital
Pharmacies, Retail Pharmacies, Online Sales and Other
Distribution Channels - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 30: USA Historic Review for Prostate Cancer Therapeutics
by Distribution Channel - Hospital Pharmacies, Retail
Pharmacies, Online Sales and Other Distribution Channels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 31: USA 16-Year Perspective for Prostate Cancer
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital Pharmacies, Retail Pharmacies, Online
Sales and Other Distribution Channels for the Years 2014, 2023 &
2030

CANADA
Table 32: Canada Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy,
Targeted Therapy and Chemotherapy - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 33: Canada Historic Review for Prostate Cancer
Therapeutics by Therapy Type - Hormone Therapy, Targeted
Therapy and Chemotherapy Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 34: Canada 16-Year Perspective for Prostate Cancer
Therapeutics by Therapy Type - Percentage Breakdown of Value
Sales for Hormone Therapy, Targeted Therapy and Chemotherapy
for the Years 2014, 2023 & 2030

Table 35: Canada Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Distribution Channel - Hospital
Pharmacies, Retail Pharmacies, Online Sales and Other
Distribution Channels - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 36: Canada Historic Review for Prostate Cancer
Therapeutics by Distribution Channel - Hospital Pharmacies,
Retail Pharmacies, Online Sales and Other Distribution Channels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 37: Canada 16-Year Perspective for Prostate Cancer
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital Pharmacies, Retail Pharmacies, Online
Sales and Other Distribution Channels for the Years 2014, 2023 &
2030

JAPAN
Prostate Cancer Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 38: Japan Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy,
Targeted Therapy and Chemotherapy - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 39: Japan Historic Review for Prostate Cancer
Therapeutics by Therapy Type - Hormone Therapy, Targeted
Therapy and Chemotherapy Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 40: Japan 16-Year Perspective for Prostate Cancer
Therapeutics by Therapy Type - Percentage Breakdown of Value
Sales for Hormone Therapy, Targeted Therapy and Chemotherapy
for the Years 2014, 2023 & 2030

Table 41: Japan Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Distribution Channel - Hospital
Pharmacies, Retail Pharmacies, Online Sales and Other
Distribution Channels - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 42: Japan Historic Review for Prostate Cancer
Therapeutics by Distribution Channel - Hospital Pharmacies,
Retail Pharmacies, Online Sales and Other Distribution Channels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 43: Japan 16-Year Perspective for Prostate Cancer
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital Pharmacies, Retail Pharmacies, Online
Sales and Other Distribution Channels for the Years 2014, 2023 &
2030

CHINA
Prostate Cancer Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in China for 2023 (E)
Table 44: China Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy,
Targeted Therapy and Chemotherapy - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 45: China Historic Review for Prostate Cancer
Therapeutics by Therapy Type - Hormone Therapy, Targeted
Therapy and Chemotherapy Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 46: China 16-Year Perspective for Prostate Cancer
Therapeutics by Therapy Type - Percentage Breakdown of Value
Sales for Hormone Therapy, Targeted Therapy and Chemotherapy
for the Years 2014, 2023 & 2030

Table 47: China Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Distribution Channel - Hospital
Pharmacies, Retail Pharmacies, Online Sales and Other
Distribution Channels - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 48: China Historic Review for Prostate Cancer
Therapeutics by Distribution Channel - Hospital Pharmacies,
Retail Pharmacies, Online Sales and Other Distribution Channels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 49: China 16-Year Perspective for Prostate Cancer
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital Pharmacies, Retail Pharmacies, Online
Sales and Other Distribution Channels for the Years 2014, 2023 &
2030

EUROPE
Prostate Cancer Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 50: Europe Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 51: Europe Historic Review for Prostate Cancer
Therapeutics by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 52: Europe 16-Year Perspective for Prostate Cancer
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2014, 2023 & 2030

Table 53: Europe Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy,
Targeted Therapy and Chemotherapy - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 54: Europe Historic Review for Prostate Cancer
Therapeutics by Therapy Type - Hormone Therapy, Targeted
Therapy and Chemotherapy Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 55: Europe 16-Year Perspective for Prostate Cancer
Therapeutics by Therapy Type - Percentage Breakdown of Value
Sales for Hormone Therapy, Targeted Therapy and Chemotherapy
for the Years 2014, 2023 & 2030

Table 56: Europe Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Distribution Channel - Hospital
Pharmacies, Retail Pharmacies, Online Sales and Other
Distribution Channels - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 57: Europe Historic Review for Prostate Cancer
Therapeutics by Distribution Channel - Hospital Pharmacies,
Retail Pharmacies, Online Sales and Other Distribution Channels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 58: Europe 16-Year Perspective for Prostate Cancer
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital Pharmacies, Retail Pharmacies, Online
Sales and Other Distribution Channels for the Years 2014, 2023 &
2030

FRANCE
Prostate Cancer Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in France for 2023 (E)
Table 59: France Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy,
Targeted Therapy and Chemotherapy - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 60: France Historic Review for Prostate Cancer
Therapeutics by Therapy Type - Hormone Therapy, Targeted
Therapy and Chemotherapy Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 61: France 16-Year Perspective for Prostate Cancer
Therapeutics by Therapy Type - Percentage Breakdown of Value
Sales for Hormone Therapy, Targeted Therapy and Chemotherapy
for the Years 2014, 2023 & 2030

Table 62: France Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Distribution Channel - Hospital
Pharmacies, Retail Pharmacies, Online Sales and Other
Distribution Channels - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 63: France Historic Review for Prostate Cancer
Therapeutics by Distribution Channel - Hospital Pharmacies,
Retail Pharmacies, Online Sales and Other Distribution Channels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 64: France 16-Year Perspective for Prostate Cancer
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital Pharmacies, Retail Pharmacies, Online
Sales and Other Distribution Channels for the Years 2014, 2023 &
2030

GERMANY
Prostate Cancer Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 65: Germany Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy,
Targeted Therapy and Chemotherapy - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 66: Germany Historic Review for Prostate Cancer
Therapeutics by Therapy Type - Hormone Therapy, Targeted
Therapy and Chemotherapy Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 67: Germany 16-Year Perspective for Prostate Cancer
Therapeutics by Therapy Type - Percentage Breakdown of Value
Sales for Hormone Therapy, Targeted Therapy and Chemotherapy
for the Years 2014, 2023 & 2030

Table 68: Germany Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Distribution Channel - Hospital
Pharmacies, Retail Pharmacies, Online Sales and Other
Distribution Channels - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 69: Germany Historic Review for Prostate Cancer
Therapeutics by Distribution Channel - Hospital Pharmacies,
Retail Pharmacies, Online Sales and Other Distribution Channels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 70: Germany 16-Year Perspective for Prostate Cancer
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital Pharmacies, Retail Pharmacies, Online
Sales and Other Distribution Channels for the Years 2014, 2023 &
2030

ITALY
Table 71: Italy Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy,
Targeted Therapy and Chemotherapy - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 72: Italy Historic Review for Prostate Cancer
Therapeutics by Therapy Type - Hormone Therapy, Targeted
Therapy and Chemotherapy Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 73: Italy 16-Year Perspective for Prostate Cancer
Therapeutics by Therapy Type - Percentage Breakdown of Value
Sales for Hormone Therapy, Targeted Therapy and Chemotherapy
for the Years 2014, 2023 & 2030

Table 74: Italy Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Distribution Channel - Hospital
Pharmacies, Retail Pharmacies, Online Sales and Other
Distribution Channels - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 75: Italy Historic Review for Prostate Cancer
Therapeutics by Distribution Channel - Hospital Pharmacies,
Retail Pharmacies, Online Sales and Other Distribution Channels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 76: Italy 16-Year Perspective for Prostate Cancer
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital Pharmacies, Retail Pharmacies, Online
Sales and Other Distribution Channels for the Years 2014, 2023 &
2030

UNITED KINGDOM
Prostate Cancer Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United Kingdom for 2023
(E)
Table 77: UK Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy,
Targeted Therapy and Chemotherapy - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 78: UK Historic Review for Prostate Cancer Therapeutics
by Therapy Type - Hormone Therapy, Targeted Therapy and
Chemotherapy Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 79: UK 16-Year Perspective for Prostate Cancer
Therapeutics by Therapy Type - Percentage Breakdown of Value
Sales for Hormone Therapy, Targeted Therapy and Chemotherapy
for the Years 2014, 2023 & 2030

Table 80: UK Recent Past, Current & Future Analysis for
Prostate Cancer Therapeutics by Distribution Channel - Hospital
Pharmacies, Retail Pharmacies, Online Sales and Other
Distribution Channels - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 81: UK Historic Review for Prostate Cancer Therapeutics
by Distribution Channel - Hospital Pharmacies, Retail
Pharmacies, Online Sales and Other Distribution Channels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 82: UK 16-Year Perspective for Prostate Cancer
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital Pharmacies, Retail Pharmacies, Online
Sales and Other Distribution Channels for the Years 2014, 2023 &
2030

REST OF EUROPE
Table 83: Rest of Europe Recent Past, Current & Future Analysis
for Prostate Cancer Therapeutics by Therapy Type - Hormone
Therapy, Targeted Therapy and Chemotherapy - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 84: Rest of Europe Historic Review for Prostate Cancer
Therapeutics by Therapy Type - Hormone Therapy, Targeted
Therapy and Chemotherapy Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 85: Rest of Europe 16-Year Perspective for Prostate
Cancer Therapeutics by Therapy Type - Percentage Breakdown of
Value Sales for Hormone Therapy, Targeted Therapy and
Chemotherapy for the Years 2014, 2023 & 2030

Table 86: Rest of Europe Recent Past, Current & Future Analysis
for Prostate Cancer Therapeutics by Distribution Channel -
Hospital Pharmacies, Retail Pharmacies, Online Sales and Other
Distribution Channels - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 87: Rest of Europe Historic Review for Prostate Cancer
Therapeutics by Distribution Channel - Hospital Pharmacies,
Retail Pharmacies, Online Sales and Other Distribution Channels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 88: Rest of Europe 16-Year Perspective for Prostate
Cancer Therapeutics by Distribution Channel - Percentage
Breakdown of Value Sales for Hospital Pharmacies, Retail
Pharmacies, Online Sales and Other Distribution Channels for
the Years 2014, 2023 & 2030

ASIA-PACIFIC
Prostate Cancer Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 89: Asia-Pacific Recent Past, Current & Future Analysis
for Prostate Cancer Therapeutics by Therapy Type - Hormone
Therapy, Targeted Therapy and Chemotherapy - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 90: Asia-Pacific Historic Review for Prostate Cancer
Therapeutics by Therapy Type - Hormone Therapy, Targeted
Therapy and Chemotherapy Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 91: Asia-Pacific 16-Year Perspective for Prostate Cancer
Therapeutics by Therapy Type - Percentage Breakdown of Value
Sales for Hormone Therapy, Targeted Therapy and Chemotherapy
for the Years 2014, 2023 & 2030

Table 92: Asia-Pacific Recent Past, Current & Future Analysis
for Prostate Cancer Therapeutics by Distribution Channel -
Hospital Pharmacies, Retail Pharmacies, Online Sales and Other
Distribution Channels - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 93: Asia-Pacific Historic Review for Prostate Cancer
Therapeutics by Distribution Channel - Hospital Pharmacies,
Retail Pharmacies, Online Sales and Other Distribution Channels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 94: Asia-Pacific 16-Year Perspective for Prostate Cancer
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital Pharmacies, Retail Pharmacies, Online
Sales and Other Distribution Channels for the Years 2014, 2023 &
2030

REST OF WORLD
Table 95: Rest of World Recent Past, Current & Future Analysis
for Prostate Cancer Therapeutics by Therapy Type - Hormone
Therapy, Targeted Therapy and Chemotherapy - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 96: Rest of World Historic Review for Prostate Cancer
Therapeutics by Therapy Type - Hormone Therapy, Targeted
Therapy and Chemotherapy Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 97: Rest of World 16-Year Perspective for Prostate Cancer
Therapeutics by Therapy Type - Percentage Breakdown of Value
Sales for Hormone Therapy, Targeted Therapy and Chemotherapy
for the Years 2014, 2023 & 2030

Table 98: Rest of World Recent Past, Current & Future Analysis
for Prostate Cancer Therapeutics by Distribution Channel -
Hospital Pharmacies, Retail Pharmacies, Online Sales and Other
Distribution Channels - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 99: Rest of World Historic Review for Prostate Cancer
Therapeutics by Distribution Channel - Hospital Pharmacies,
Retail Pharmacies, Online Sales and Other Distribution Channels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 100: Rest of World 16-Year Perspective for Prostate
Cancer Therapeutics by Distribution Channel - Percentage
Breakdown of Value Sales for Hospital Pharmacies, Retail
Pharmacies, Online Sales and Other Distribution Channels for
the Years 2014, 2023 & 2030

IV. COMPETITION
Read the full report: https://www.reportlinker.com/p03915682/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001